These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2978385)

  • 1. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
    Machka K; Milatovic D; Braveny I
    Chemioterapia; 1987 Jun; 6(2 Suppl):117-8. PubMed ID: 2978385
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vitro and in vivo antibacterial activity of amoxicillin-flucloxacillin combination (1:1 ratio).
    Ravagnan G; Oliva B; Nicoletti M; Piccolomini R
    Antibiotica; 1974 Mar; 12(1):40-55. PubMed ID: 4469965
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiological properties in vitro and in vivo of the flucloxacillin and ampicillin combination (author's transl).
    Renzini G; Bevilacqua R; Dominici A; Salvetti E
    Antibiotica; 1973 Jun; 11(2):77-98. PubMed ID: 4806148
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ; Le Van Thoi J; Duval JR
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activities of three new antibacterial agents with aztreonam against gram-negative bacilli.
    Kafetzis DA; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):110-2. PubMed ID: 3151330
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antibacterial action of the amoxicillin-flucloxacillin combination].
    Carlone NA; Savoia D; Martinetto P
    G Batteriol Virol Immunol; 1975; 68(7-12):289-300. PubMed ID: 1234595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chemotherapeutic antagonism in opportunistic infections.
    Castelli M; Baggio G; Ruberto AI; Malagoli M; Casolari C; Rossi T; Galatulas I
    Anticancer Res; 1997; 17(6D):4339-44. PubMed ID: 9494530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P; Klastersky J
    Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
    Van der Auwera P; Joly P
    J Antimicrob Chemother; 1987 Mar; 19(3):313-20. PubMed ID: 3032884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flucloxacillin].
    Mastroviti S; Cassarino G
    G Batteriol Virol Immunol; 1975; 68(7-12):279-88. PubMed ID: 1234594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabilities.
    Tawfik AF
    J Chemother; 1991 Aug; 3(4):226-31. PubMed ID: 1663995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
    Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ciprofloxacin.
    Ferrara A; Donnetta A; Grassi FA; Gialdroni Grassi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):130-1. PubMed ID: 3151333
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro effect of combinations of netilmicin with aztreonam against Pseudomonas aeruginosa.
    Tumah H; Velonaki A; Michalitsianos D; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):128-9. PubMed ID: 3151332
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo experience with carumonam: a preliminary report.
    Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
    J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.
    Govan JR; Fyfe JA
    J Antimicrob Chemother; 1978 May; 4(3):233-40. PubMed ID: 97259
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative in vitro activity of CI934, a new fluoroquinolone, alone and in combination with coumermycin, against gram-positive bacteria.
    van der Auwera P; Vandermies A; Grenier P; Klastersky J
    Drugs Exp Clin Res; 1987; 13(3):125-32. PubMed ID: 3622241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.